Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma

Laboratory Investigation

Volumn 76, Issue 5, 1997, Pages 651-660

  Gilles, Christine ^a   Polette, Myriam ^b   Seiki, Motoharu ^c   Birembaut, Philippe ^b   Thompson, Erik W ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GELATINASE A;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COLLAGEN; ENZYME ACTIVATION; ENZYME INDUCTION; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 0030922614     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Aimes RT and Quigley JP (1995). Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem 270:5872-5876.
2. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, and Murphy G (1995). Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270:30479-30485.
3. Azzam HS and Thompson EW (1992). Collagen-induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res 52:4540-4544.
4. Azzam H, Arrand GA, Lippman ME, and Thompson EW (1993). MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. J Natl Cancer Inst 85: 1758-1764.
5. Barsky S, Green W, Grotendorst G, and Liotta LA (1984). Desmoplastic breast carcinoma as a source of human fibroblasts. Am J Pathol 115:329-333.
6. Brown PD, Levy AT, Margulies IM, Liotta LA, and Stetler-Stevenson WG (1990). Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50:6184-6191.
7. Clavel C, Doco M, Lallemand A, Laurent M, and Birembaut P (1989). Detection by in situ hybridization of messenger RNAs of collagen types I and IV in murine mammary cancer. Int J Cancer 44:548-553.
8. Deak SB, Glaug MR, Pierce RA, Bancila E, Amenta P, Mackenzie JW, Greco RS, and Boyd CD (1991). Desmoplasia in benign and malignant breast disease is characterized by alterations in level of mRNAs coding for type I and III procollagen. Matrix 11:252-258.
9. Fuchs E and Weber K (1994). Intermediate filaments: Structure, dynamic, function, and disease. Annu Rev Biochem 63:345-382.
10. Gilles C, Polette M, Piette J, Birembaut P, and Foidart JM (1994). Epithelial to mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer 59:661-666.
11. Gilles C, Polette M, Piette J, Delvigne AC, Thompson EW, Foidart JM, and Birembaut P (1996a). Vimentin expression in cervical carcinomas: Association with the invasive and the migratory phenotype of tumor cells. J Pathol 180:175-180.
12. Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P, and Foidart JM (1996b). High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65:209-213.
13. Gilles C and Thompson EW (1996). The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast J 2:83-96.
14. Guarino M (1995). Epithelial-to-mesenchymal change of differentiation: From embryogenetic mechanism to pathological patterns. Histol Histopathol 10:171-184.
15. Hay ED and Zuk A (1995). Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced. Am J Kidney Dis 26:678-690.
16. Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, and Seki M (1996). Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane type 1 matrix metalloproteinase. Cancer Res 59:2535-2538.
17. Lohi J and Keski-Oja J (1995). Calcium ionophore decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem 270:17602-17609.
18. MacDougall JR and Matrisian L (1995). Contribution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14:351-362.
19. Mahfouz S, Chevallier M, and Grimaud J (1987). Distribution of the major matrix components of the stromal reaction in breast carcinoma. Cell Mol Biol 33:453-467.
20. Martinez-Hernandez A (1988). The extracellular matrix and neoplasia. Lab Invest 58:609-612.
21. Minafra S, Pucci-Minafra I, Tomasino R, and Sciarrino S (1984). Collagen composition in the ductal infiltrating carcinoma of human breast. Cell Biol Int Rep 84:79-85.
22. Noël A, Munaut C, Boulvain A, Calberg-Bacq CM, Lambert CA, Nusgens B, Lapière CM, and Foidart JM (1992). Modulation of collagen and fibronectin synthesis in fibroblasts by normal and malignant cells. J Cell Biochem 48:150-161.
23. Nomura H, Sato H, Seiki M, Mai M, and Okada Y (1995). Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55:3263-3266.
24. Ohtani H, Nagai T, and Nagura H (1995). Similarities of in situ mRNA expression between gelatinase A (MMP-2) and type I procollagen in human gastrointestinal carcinoma: Comparison with granulation tissue reaction. Jpn J Cancer Res 86:833-839.
25. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, and Basset P (1995). Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734.
26. Overall CM and Sodek J (1990). Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J Biol Chem 265:21141-21151.
27. Pei D and Weiss SJ (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271:9135-9140.
28. Polette M and Birembaut P (1996). Matrix metalloproteinases in breast carcinoma. Breast J 2:209-220.
29. Polette M, Gilles C, Marchand V, Seiki M, Tournier JM, and Birembaut P (1997). Induction of membrane type matrix metalloproteinase (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. Clin Exp Metastasis 15:157-163.
30. Polette M, Nawrocki B, Gilles C, Seiki M, Sato H, Tournier JM, and Birembaut P (1996). MT-MMP expression and localisation in human breast and lung cancers. Virchows Arch 428:29-35.
31. Pucci-Minafra I, Luparello C, Sciarrino S, Tomasino R, and Minafra S (1985). Quantitative determination of collagen types present in the ductal carcinoma of human mammary gland. Cell Biol Int Rep 9:291-296.
32. Puente XS, Pendas AM, Llano E, Velasco G, and Lopez-Otin C (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949.
33. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
34. Savagner P, Boyer B, Valles AM, Jouanneau J, and Thiery JP (1994). Modulations of the epithelial phenotype during embryogenesis and cancer progression. In: Dickson R and Lippman M, editors. Mammary tumorigenesis and malignant progression. Norwell: Kluwer Academic Publishers, 229-249.
35. Seltzer JL, Lee AY, Akers KT, Subdeck B, Southon EA, Wayner EA, and Eisen AZ (1994). Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res 213:365-374.
36. Sommers CL, Byers SW, Thompson EW, Torri J, and Gelmann EP (1994). Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31:325-335.
37. Sommers C, Walker-Jones D, Heckford SE, Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach S, and Gelmann EP (1989). Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 49:4258-4263.
38. Stetler-Stevenson WG (1994-95). Progelatinase A activation during tumor cell invasion. Invasion Metastasis 14:259-268.
39. Stetler-Stevenson WG, Aznavoorian S, and Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573.
40. Takino T, Sato H, Shinagawa A, and Seiki M (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP2) gene from a human placenta cDNA library. J Biol Chem 270:23010-23020.
41. Thompson EW, Paik S, Brünner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR, and Dickson RB (1992). Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150:534-544.
42. Thompson EW, Yu M, Bueno J, Jin L, Maiti S, Palao-Marco F, Pulyaeva H, Tamborlane J, Tirgari R, Wapnir I, and Azzam H (1994). Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat 31:357-370.
43. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, and Seiki M (1995). Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64:355-359.
44. Tournier JM, Polette M, Hinnraski J, Beck J, Werb Z, and Basbaum C (1994). Expression of gelatinase A, a mediator of extracellular matrix remodeling, by tracheal gland serous cells in culture and in vivo. J Biol Chem 41:25454-25464.
45. Ward RV, Atkinson SJ, Slocombe PM, Docherty AJP, Reynolds JJ, and Murphy G (1991). Tissue inihibitor of metalloproteinases-2 inihibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochem Biophys Acta 1079:242-246.
46. Will H and Hinzmann B (1995). cDNA sequence and mRNA distribution of a novel human matrix metalloproteinase with a potential transmembrane domain. Eur J Biochem 231:602-608.
47. Yamamoto M, Mohanan S, Sawaya R, Fuller GN, Seiki M, Sato H, Golaslan ZL, Liotta LA, Nilcolson GL, and Rao JS (1996). Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384-392.
48. Yu M, Sato H, Seiki M, and Thompson EW (1995). Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55:3272-3277.
49. Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M, and Bahou WF (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 270:23730-23738.